Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript May 6, 2026Castle Biosciences, Inc. reports earnings inline with expectations.
Castle Biosciences Inc (CSTL)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 647,391 | $15,440,275 | 0.1% | |
| 2. | AIGH Investment Partners Orin Hirschman | 545,101 | $13,000,659 | -8% | 0.82% |
| 3. | Renaissance Technologies Jim Simons | 371,200 | $8,853,120 | -31% | 0.01% |
| 4. | Point72 Asset Management Steve Cohen | 357,317 | $8,522,010 | 0.01% | |
| 5. | Portolan Capital Management George Mccabe | 328,818 | $7,842,309 | -76% | 0.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.27 | 2,500 | $43,175.00 | 9,065 | 2023-06-05 | Filing | |
| $11.23 | 2,300 | $25,829.00 | 6,565 | 2023-06-05 | Filing | |
| $21.50 | 1,162 | $24,983.00 | 2,968 | 2022-11-29 | Filing | |
| $18.77 | 220 | $4,129.40 | 1,806 | 2022-05-12 | Filing | |
| $18.76 | 1,100 | $20,636.00 | 1,586 | 2022-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.59 | 1,730 | $51,190.70 | 75,964 | 2026-08-17 | Filing | |
| $29.77 | 24,908 | $741,511.16 | 35,177 | 2026-08-14 | Filing | |
| $30.02 | 278 | $8,345.56 | 11,534 | 2026-08-14 | Filing | |
| $30.02 | 278 | $8,345.56 | 11,534 | 2026-08-14 | Filing | |
| $30.02 | 278 | $8,345.56 | 11,534 | 2026-08-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,291,963 | $78,513,319 | 0% | |
| 2. | 2,778,335 | $66,263,290 | 0.57% | |
| 3. | 1,726,648 | $41,180,555 | 0.02% | |
| 4. | 1,226,497 | $29,251,953 | 0% | |
| 5. | 840,785 | $20,052,722 | 0% |
News See All
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2025 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences' Third Quarter 2025 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2025 Earnings Call Transcript
Operator: Good afternoon all, and thank you for joining us for the Castle Biosciences' Q2 2025 Earnings Call. As a reminder, this call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript
Operator: Good afternoon and welcome to Castle Biosciences First Quarter 2025 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2024 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Third Quarter 2024 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Second Quarter 2024 Conference Call. As a remainder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences First Quarter 2024 Conference Call. As a remainder, today's call is being recorded.